Drugmaker Pfizer has sold its entire stake in Haleon for about 2.5 billion pounds ($3.24 billion) to institutional investors and the consumer healthcare firm at 385 pence per share, a bookrunner for ...

The information regarding this proposed off-market purchase and share buyback initiative is based on a press release statement from Haleon plc. Further developments will be reported following the ...